報價延遲最少15分鐘:2026/03/02 20:00 EST
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.95 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-5.28/-1.98
|
|
企業價值
39.18M
|
| 資產負債 |
|
每股賬面淨值
4.05
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
3.63M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies. |
